We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Global Artificial Intelligence in Diagnostics Market to Surpass USD 5.6 Billion by 2027

By LabMedica International staff writers
Posted on 08 Mar 2022
Print article
Image: AI in diagnostics market to grow more than 33% by 2027 (Photo courtesy of Unsplash)
Image: AI in diagnostics market to grow more than 33% by 2027 (Photo courtesy of Unsplash)

The global artificial intelligence (AI) in diagnostics market was valued at USD 300 million in 2020 and is expected to register a CAGR of around 33.5% over the period 2022 to 2027 to surpass USD 5.6 billion by 2027. The market growth will be driven by increasing interest in lowering the cost of disease determination, improving patient consideration, reducing machine personnel time, growing interest in AI, and the need for cost effective symptomatic advancements and approaches, as well as proficient report investigation.

These are the latest findings of Precedence Research (Ottawa, ON, Canada), a market research services provider.

AI is the building of unique systems using algorithms and software that can complete activities without the need for human interaction or instructions. Natural language processing, machine learning, and reasoning are some of the technologies that make up AI. In diagnostics, AI is utilized to approximate human cognition and to analyze complicated diagnostic imaging and medical data. Image analysis for tumor diagnosis, biochemical tests for diabetes, video detection for gait problems and fall prediction, and voice analysis for emotional state and psychiatric illnesses are just some of the many applications of AI in medical diagnostics. As a result, AI will significantly alter the current medical diagnosing approach.

The healthcare sector is increasingly integrating AI-powered solutions in multiple verticals to improve clinical and operational outcomes, which is a critical contributor to the growth of the AI in diagnostics market. The desire for innovative and automated processes is being driven by overwhelmed healthcare systems having to cope with the fast-expanding global prevalence of chronic disorders. Moreover, a scarcity of caregivers is fueling the demand for AI technologies. Advances in healthcare information technology infrastructure as well as ongoing technological developments are enabling the integration of AI-powered diagnostic systems to provide precise and effective diagnosis, enabling healthcare providers to devise timely and appropriate diagnostic plans. AI-based algorithms are increasingly being used in radiology and pathology services on a large scale.

Based on component, the software and services segment dominated the global AI in diagnostics market in 2020 with the highest market share. The segment’s growth can be attributed to the growing demand for AI-enabled diagnostics systems that can provide correct diagnoses as soon as possible. A wide range of chronic and acute disorders are being rapidly detected in the worldwide population, which is projected to boost demand for improved AI-enabled solutions. Based on diagnosis type, the neurology segment dominated the global AI in diagnostics market in 2020 with the highest market share. The expanding trend of using value-based care to combat the burden of neurological illnesses is propelling market growth. The segment’s expansion is being fueled by the development of deep entangled neural networks and advanced algorithms trained on different image datasets obtained for various diagnosis.

Geographically, North America holds the largest share in the global AI in diagnostics market due to constant technological developments, robust healthcare information technology infrastructure, favorable government initiatives, increasing digital literacy, and the presence of major market players in the region. However, Asia-Pacific is the world’s fastest growing AI in diagnostics market due to a rise in the number of private and public initiatives supporting the adoption of AI-based diagnostic solutions, the introduction of startups as well as increasing visibility and funding in the region.

Related Links:
Precedence Research 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.